IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Purchased by AlphaCrest Capital Management LLC

AlphaCrest Capital Management LLC lifted its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXXGet Rating) by 42.8% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 3,302 shares of the company’s stock after buying an additional 990 shares during the quarter. AlphaCrest Capital Management LLC’s holdings in IDEXX Laboratories were worth $1,806,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Norges Bank bought a new position in shares of IDEXX Laboratories during the fourth quarter valued at approximately $494,883,000. American Century Companies Inc. grew its position in shares of IDEXX Laboratories by 32.1% during the first quarter. American Century Companies Inc. now owns 1,423,600 shares of the company’s stock worth $778,795,000 after acquiring an additional 346,118 shares during the last quarter. BlackRock Inc. grew its position in IDEXX Laboratories by 3.4% in the 4th quarter. BlackRock Inc. now owns 8,990,586 shares of the company’s stock worth $5,919,940,000 after purchasing an additional 296,552 shares during the last quarter. UMB Bank N A MO increased its position in IDEXX Laboratories by 4,072.8% in the 4th quarter. UMB Bank N A MO now owns 287,464 shares of the company’s stock valued at $189,284,000 after acquiring an additional 280,575 shares during the period. Finally, Alliancebernstein L.P. raised its stake in IDEXX Laboratories by 18.9% during the 4th quarter. Alliancebernstein L.P. now owns 1,596,308 shares of the company’s stock valued at $1,051,105,000 after acquiring an additional 254,033 shares in the last quarter. 88.45% of the stock is owned by institutional investors and hedge funds.

IDEXX Laboratories Stock Performance

Shares of IDXX opened at $348.84 on Wednesday. IDEXX Laboratories, Inc. has a one year low of $318.50 and a one year high of $695.18. The company has a 50-day moving average of $375.30 and a two-hundred day moving average of $427.07. The company has a debt-to-equity ratio of 1.68, a current ratio of 0.89 and a quick ratio of 0.61. The stock has a market cap of $29.04 billion, a price-to-earnings ratio of 45.01, a PEG ratio of 4.65 and a beta of 1.14.

Analysts Set New Price Targets

IDXX has been the topic of a number of research analyst reports. Piper Sandler lowered their price target on IDEXX Laboratories from $500.00 to $420.00 in a report on Monday, August 8th. Atlantic Securities dropped their target price on IDEXX Laboratories from $500.00 to $490.00 and set an “overweight” rating on the stock in a report on Wednesday, August 3rd. Bank of America cut IDEXX Laboratories from a “buy” rating to a “neutral” rating and lowered their price target for the company from $550.00 to $470.00 in a research report on Thursday, May 5th. The Goldman Sachs Group upgraded IDEXX Laboratories from a “neutral” rating to a “buy” rating and cut their price objective for the company from $530.00 to $435.00 in a report on Thursday, July 21st. Finally, StockNews.com lowered IDEXX Laboratories from a “buy” rating to a “hold” rating in a report on Monday, July 25th. Three analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $483.57.

IDEXX Laboratories Profile

(Get Rating)

IDEXX Laboratories, Inc develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community.

Featured Articles

Want to see what other hedge funds are holding IDXX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IDEXX Laboratories, Inc. (NASDAQ:IDXXGet Rating).

Institutional Ownership by Quarter for IDEXX Laboratories (NASDAQ:IDXX)

Receive News & Ratings for IDEXX Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEXX Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.